Literature DB >> 29949757

Mutant p53-Expressing Cells Undergo Necroptosis via Cell Competition with the Neighboring Normal Epithelial Cells.

Hirotaka Watanabe1, Kojiro Ishibashi1, Hiroki Mano1, Sho Kitamoto2, Nanami Sato1, Kazuya Hoshiba1, Mugihiko Kato2, Fumihiko Matsuzawa2, Yasuto Takeuchi2, Takanobu Shirai1, Susumu Ishikawa2, Yuka Morioka3, Toshiaki Imagawa4, Kazuyasu Sakaguchi4, Suguru Yonezawa5, Shunsuke Kon6, Yasuyuki Fujita7.   

Abstract

p53 is a tumor suppressor protein, and its missense mutations are frequently found in human cancers. During the multi-step progression of cancer, p53 mutations generally accumulate at the mid or late stage, but not in the early stage, and the underlying mechanism is still unclear. In this study, using mammalian cell culture and mouse ex vivo systems, we demonstrate that when p53R273H- or p53R175H-expressing cells are surrounded by normal epithelial cells, mutant p53 cells undergo necroptosis and are basally extruded from the epithelial monolayer. When mutant p53 cells alone are present, cell death does not occur, indicating that necroptosis results from cell competition with the surrounding normal cells. Furthermore, when p53R273H mutation occurs within RasV12-transformed epithelia, cell death is strongly suppressed and most of the p53R273H-expressing cells remain intact. These results suggest that the order of oncogenic mutations in cancer development could be dictated by cell competition.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  MDCK cells; RasV12; cell competition; mouse intestinal organoids; multi-step cancer progression; necroptosis; p53; p53R175H; p53R273H

Mesh:

Substances:

Year:  2018        PMID: 29949757     DOI: 10.1016/j.celrep.2018.05.081

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  14 in total

1.  Cellular Nrf2 Levels Determine Cell Fate during Chemical Carcinogenesis in Esophageal Epithelium.

Authors:  Makoto Horiuchi; Keiko Taguchi; Wataru Hirose; Kouhei Tsuchida; Mikiko Suzuki; Yusuke Taniyama; Takashi Kamei; Masayuki Yamamoto
Journal:  Mol Cell Biol       Date:  2021-01-25       Impact factor: 4.272

Review 2.  Cell competition in development, homeostasis and cancer.

Authors:  Sanne M van Neerven; Louis Vermeulen
Journal:  Nat Rev Mol Cell Biol       Date:  2022-09-29       Impact factor: 113.915

Review 3.  Pleiotropic effects of cell competition between normal and transformed cells in mammalian cancers.

Authors:  Jing Yu; Yamin Zhang; Huiyong Zhu
Journal:  J Cancer Res Clin Oncol       Date:  2022-07-07       Impact factor: 4.322

4.  Epithelial cells remove precancerous cells by cell competition via MHC class I-LILRB3 interaction.

Authors:  Nagisa Kamoshita; Jun Nakayama; Shiyu Ayukawa; Ryohei Teramoto; Novalia Pishesha; Kenji Ohba; Nanami Sato; Kei Kozawa; Hikari Abe; Kentaro Semba; Nobuhito Goda; Yasuyuki Fujita; Takeshi Maruyama
Journal:  Nat Immunol       Date:  2021-10-22       Impact factor: 31.250

Review 5.  Somatic Mutation: What Shapes the Mutational Landscape of Normal Epithelia?

Authors:  Joanna C Fowler; Philip H Jones
Journal:  Cancer Discov       Date:  2022-07-06       Impact factor: 38.272

Review 6.  Outcompeting cancer.

Authors:  Medhavi Vishwakarma; Eugenia Piddini
Journal:  Nat Rev Cancer       Date:  2020-01-13       Impact factor: 60.716

7.  GPR30-Expressing Gastric Chief Cells Do Not Dedifferentiate But Are Eliminated via PDK-Dependent Cell Competition During Development of Metaplasia.

Authors:  Masahiro Hata; Hiroto Kinoshita; Yoku Hayakawa; Mitsuru Konishi; Mayo Tsuboi; Yukiko Oya; Ken Kurokawa; Yuki Hayata; Hayato Nakagawa; Keisuke Tateishi; Hiroaki Fujiwara; Yoshihiro Hirata; Daniel L Worthley; Yuki Muranishi; Takahisa Furukawa; Shunsuke Kon; Hiroyuki Tomita; Timothy C Wang; Kazuhiko Koike
Journal:  Gastroenterology       Date:  2020-02-04       Impact factor: 22.682

8.  Reverse Transcriptase Inhibition Disrupts Repeat Element Life Cycle in Colorectal Cancer.

Authors:  Mihir Rajurkar; Aparna R Parikh; Alexander Solovyov; Eunae You; Anupriya S Kulkarni; Chong Chu; Katherine H Xu; Christopher Jaicks; Martin S Taylor; Connie Wu; Katherine A Alexander; Charly R Good; Annamaria Szabolcs; Stefanie Gerstberger; Antuan V Tran; Nova Xu; Richard Y Ebright; Emily E Van Seventer; Kevin D Vo; Eric C Tai; Chenyue Lu; Jasmin Joseph-Chazan; Michael J Raabe; Linda T Nieman; Niyati Desai; Kshitij S Arora; Matteo Ligorio; Vishal Thapar; Limor Cohen; Padric M Garden; Yasmeen Senussi; Hui Zheng; Jill N Allen; Lawrence S Blaszkowsky; Jeffrey W Clark; Lipika Goyal; Jennifer Y Wo; David P Ryan; Ryan B Corcoran; Vikram Deshpande; Miguel N Rivera; Martin J Aryee; Theodore S Hong; Shelley L Berger; David R Walt; Kathleen H Burns; Peter J Park; Benjamin D Greenbaum; David T Ting
Journal:  Cancer Discov       Date:  2022-06-02       Impact factor: 38.272

9.  Deregulated lncRNA expression profile in the mouse lung adenocarcinomas with KRAS-G12D mutation and P53 knockout.

Authors:  Meiqin Zhang; Nan Jiang; Renjie Cui; Sichen Du; Huayuan Ou; Tinglan Chen; Runsheng Ge; Duan Ma; Jin Zhang
Journal:  J Cell Mol Med       Date:  2019-08-14       Impact factor: 5.310

Review 10.  Mutant p53 in cell-cell interactions.

Authors:  Steven Pilley; Tristan A Rodriguez; Karen H Vousden
Journal:  Genes Dev       Date:  2021-04-01       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.